CDSCO License for Ankle joint metal/polymer non-constrained cemented prosthesis
Medical Device Information
Intended Use
A device intended to be implanted to replace an ankle joint. The device limits minimally translation in one or more planes. It has no linkage across- the-joint.

Comprehensive Guide to CDSCO Licensing for Ankle Joint Metal/Polymer Non-Constrained Cemented Prosthesis (Class C)
Navigating the regulatory landscape in India for a Class C medical device like the ankle joint metal/polymer non-constrained cemented prosthesis can be complex. With over 25 years of experience assisting 500+ companies, we provide you with an actionable and detailed roadmap to secure your CDSCO license efficiently.
Understanding Your Device and Its Regulatory Importance
The ankle joint metal/polymer non-constrained cemented prosthesis is a critical orthopaedic implant designed to replace the ankle joint by limiting minimal translation across one or more planes. Classified under risk class C, this device requires stringent regulatory oversight due to its invasive nature and the associated patient safety risks.
Adhering to CDSCO regulations ensures compliance with Indian medical device laws, enabling market access and safeguarding patient well-being. Non-compliance can result in delays, penalties, or denial of market entry.
CDSCO Regulatory Framework for Orthopaedic Implants (Class C)
Orthopaedic implants such as your ankle joint prosthesis fall under risk class C, implicating moderate to high risk due to their implantable and functional nature. The central licensing authority governs the approval process for such devices, mandating an MD9 manufacturing license for Indian manufacturers and an MD15 import license for foreign manufacturers or importers.
This classification aligns with the CDSCO’s medical device classification, ensuring you follow the correct pathways.
Risk Classification and License Requirements for Your Device
- Device Risk Class: C
- License Type for Manufacture: MD9 (Form MD7)
- License Type for Import: MD15 (Form MD14)
Manufacturers must obtain the MD9 license granted by the Central Licensing Authority, while importers require the MD15 license. The process involves rigorous documentation, audits, and testing to ensure compliance with safety and performance standards.
Manufacturing License Process (MD9) for Class C Devices
Obtaining an MD9 license involves several critical steps:
- Test License (Form MD13): Mandatory pre-requisite allowing you to manufacture under controlled conditions for testing. Duration: 1.5 to 2 months.
- Product Testing: Conducted at CDSCO-approved laboratories (Testing Laboratories) to validate safety and efficacy.
- Document Preparation: Compilation of comprehensive documentation including Device Master File and Plant Master File.
- Application Submission: Filing Form MD7 on the CDSCO MD Online Portal with all required documents.
- Audit Inspection: CDSCO inspectors perform a detailed audit of your manufacturing site and quality management system.
- Query Resolution: Address any queries or observations raised by CDSCO or audit teams.
- License Grant: Upon satisfactory compliance, MD9 license is issued.
Refer to our detailed MD9 License Guide for step-by-step support.
Manufacturing License Documents Required
Ensure the following documents are meticulously prepared and submitted:
- Company constitution and incorporation certificates
- Proof of ownership or lease agreement of the manufacturing premises
- Details and qualifications of technical staff
- Fire and pollution No Objection Certificates (NOCs)
- Device Master File (DMF): Detailed description of device design and manufacturing (Device Master File guide)
- Plant Master File (PMF): Overview of manufacturing processes and quality controls (Plant Master File guide)
- Essential Principles Checklist demonstrating compliance with Indian regulations
- Risk Management File addressing potential hazards (Risk Management)
- Test Reports from CDSCO-approved labs
- Labels and Instructions for Use (IFU)
- Quality Management System (QMS) documentation, preferably ISO 13485:2016 certification
Organizing these documents early can prevent delays during application review.
Import License Process (MD15) for Class C Devices
For importers, the MD15 license is essential to legally bring the ankle joint prosthesis into India. The process includes:
- Document Preparation: Assemble critical documents such as manufacturing license from country of origin, Free Sale Certificate, ISO 13485:2016, CE Certificate, and Device/Plant Master Files.
- Application Submission: File Form MD14 on the CDSCO MD Online Portal.
- Review and Queries: CDSCO reviews the application and may raise queries.
- License Grant: After satisfactory review, the MD15 license is issued.
Unlike the manufacturing license, no test license is required. The process typically takes 5 to 6 months.
Import License Documents Required
- Valid manufacturing license from the country of origin
- Free Sale Certificate
- ISO 13485:2016 certificate
- CE Certificate or equivalent
- Device Master File
- Plant Master File
- Wholesale drug license or equivalent
- Company constitution documents
Adhering to document quality and authenticity is crucial for smooth approval.
Timeline and Processing Duration
Process Step | Duration |
---|---|
Test License (MD13) | 1.5 to 2 months |
Product Testing | 1 to 1.5 months |
MD9 License Application | 4 to 5 months total process |
MD15 Import License | 5 to 6 months |
Planning your submissions according to these timelines can help align your market launch.
Government Fees and Costs
- MD9 Manufacturing License:
- Application Fee: ₹50,000
- Per Product Fee: ₹1,000
- Test License (MD13): Included in overall process
- MD15 Import License Fees:
- Class C & D: ₹3,000 per site + ₹1,500 per product
These fees are payable online via the CDSCO portal and are non-refundable.
Common Challenges and Solutions
- Documentation Gaps: Incomplete or inconsistent documents often cause delays. Solution: Use checklists and professional templates.
- Testing Delays: Limited slots in government labs may extend timelines. Solution: Early booking and considering notified private labs.
- Audit Non-compliance: Poor QMS or facility conditions can result in non-conformances. Solution: Conduct internal audits and pre-audit readiness assessments.
- Query Management: Delayed responses to CDSCO queries prolong the process. Solution: Assign dedicated regulatory personnel for timely replies.
Expert Consultation and Support
Given the complexities involved, partnering with experienced consultants can accelerate your licensing journey. Our expertise spans over 500 successful CDSCO approvals for orthopaedic implants, offering:
- Document preparation and review
- Regulatory strategy and classification advice
- Audit readiness and corrective action support
- Liaison with CDSCO officials
Engaging expert consultants can reduce your time-to-market and minimize regulatory risks.
Getting Started with Your CDSCO License Application
To initiate your licensing process for the ankle joint metal/polymer non-constrained cemented prosthesis:
- Assess Your Status: Determine if you are a manufacturer or importer.
- Gather Preliminary Documents: Start compiling company registration, premises proof, and technical staff credentials.
- Create/Update Device and Plant Master Files: Leverage our Device Master File guide and Plant Master File guide for structured documentation.
- Apply for Test License (MD13) if Manufacturing: Submit via the CDSCO MD Online Portal.
- Plan Testing: Schedule product testing at approved labs.
- Prepare for Audit: Engage with a notified body or CDSCO inspector depending on license type.
- **Submit Manufacturing License Application (MD9) or Import License Application (MD15) accordingly.
Starting early and following this roadmap will help ensure a smooth and timely CDSCO license grant for your ankle joint prosthesis.
For personalized assistance and detailed walkthroughs, do not hesitate to reach out to our regulatory experts who have successfully guided numerous orthopaedic device manufacturers and importers to compliance and market success.